These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 32127275)

  • 1. Heparin Dose and Point-of-Care Measurements of Hemostasis in Cardiac Surgery-Results of a Randomized Controlled Trial.
    Lax M; Pesonen E; Hiippala S; Schramko A; Lassila R; Raivio P
    J Cardiothorac Vasc Anesth; 2020 Sep; 34(9):2362-2368. PubMed ID: 32127275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimum protamine dose required to neutralize heparin in cardiac surgery: a single-centre, prospective, observational cohort study.
    Taneja R; Szoke DJ; Hynes Z; Jones PM
    Can J Anaesth; 2023 Feb; 70(2):219-227. PubMed ID: 36471142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Titrated versus conventional anticoagulation management for thrombin generation in cardiac surgery: a randomized controlled trial.
    Li H; Bartoszko J; Serrick C; Rao V; Karkouti K
    Can J Anaesth; 2022 Sep; 69(9):1117-1128. PubMed ID: 35799088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the impact of different heparin dosing regimens for cardiopulmonary bypass on anticoagulation: the HepDOSE pilot study.
    Lwin TN; Mudannayake R; MacDonald S; Arrowsmith JE; Burt C; Besser M; Falter F
    Can J Anaesth; 2024 Feb; 71(2):234-243. PubMed ID: 37985627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fresh Frozen Plasma Versus Solvent Detergent Plasma for Cardiopulmonary Bypass Priming in Neonates and Infants Undergoing Cardiac Surgery: A Retrospective Cohort Study.
    van Minnen O; van den Bergh WM; Kneyber MCJ; Accord RE; Buys D; Meier S
    J Cardiothorac Vasc Anesth; 2024 May; 38(5):1144-1149. PubMed ID: 38383273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protamine titration to optimize heparin antagonization after cardiopulmonary bypass.
    Foubert R; Van Vaerenbergh G; Cammu G; Buys S; De Mey N; Lecomte P; Bouchez S; Rex S; Foubert L
    Perfusion; 2022 Dec; ():2676591221144702. PubMed ID: 36503295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clues of incomplete reversal of heparin in cardiac surgery.
    Tiquet B; Pihan F; Thomasset P; Denizou M; Tifrea M; Tifrea A; Orsel I; Marsaud JP; Jouan J; Vandroux D
    Perfusion; 2024 May; 39(4):784-789. PubMed ID: 38124316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized heparin monitoring and management reduces protamine requirements in cardiac surgery on minimal invasive extracorporeal circulation; A prospective randomized study.
    Gkiouliava A; Argiriadou H; Antonitsis P; Goulas A; Papapostolou E; Sarridou D; Karapanagiotidis GT; Anastasiadis K
    Perfusion; 2023 Sep; ():2676591231204284. PubMed ID: 37776194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finding a common definition of heparin resistance in adult cardiac surgery: communication from the ISTH SSC subcommittee on perioperative and critical care thrombosis and hemostasis.
    Levy JH; Sniecinski RM; Maier CL; Despotis GJ; Ghadimi K; Helms J; Ranucci M; Steiner ME; Tanaka KA; Connors JM
    J Thromb Haemost; 2024 Apr; 22(4):1249-1257. PubMed ID: 38215912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalizing Anti-Thrombin III for heparin management during routine cardiopulmonary bypass for congenital cardiothoracic surgery: A single institution practice review.
    Deptula J; Olshove V; Oldeen M; Kozik D; Alsoufi B
    Perfusion; 2024 Mar; ():2676591241239819. PubMed ID: 38503431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotational thromboelastometry and multiple electrode platelet aggregometry in four patients with abnormal routine coagulation studies before removal of epidural catheters after major surgery: a case series and research study.
    Thomas OD; Gustafsson A; Schött U
    J Med Case Rep; 2013 Dec; 7():282. PubMed ID: 24377397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does heparin rebound lead to postoperative blood loss in patients undergoing cardiac surgery with cardiopulmonary bypass?
    Rijpkema M; Vlot EA; Stehouwer MC; Bruins P
    Perfusion; 2023 Sep; ():2676591231199218. PubMed ID: 37734336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between antithrombin-III activity and activated clotting time for cardiopulmonary bypass.
    Yamashiro T; Takami Y; Takagi Y
    J Artif Organs; 2024 Aug; ():. PubMed ID: 39095630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose Effect of Mesenchymal Stromal Cell Delivery Through Cardiopulmonary Bypass.
    Kobayashi K; Maeda T; Ayodeji M; Tu SC; Chen A; Rajtboriraks M; Hsu CH; Tu TW; Wang PC; Hanley PJ; Jonas RA; Ishibashi N
    Ann Thorac Surg; 2023 Dec; 116(6):1337-1345. PubMed ID: 35952858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate protamine:heparin matching (not just smaller protamine doses) decreases postoperative bleeding in cardiac surgery; results from a high-volume academic medical center.
    Vespe MW; Stone ME; Lin HM; Ouyang Y
    Perfusion; 2023 Jul; ():2676591231190739. PubMed ID: 37493300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated clotting time-guided heparinization during open AAA surgery: a pilot study.
    Roosendaal LC; Hoebink M; Wiersema AM; Blankensteijn JD; Jongkind V
    Pilot Feasibility Stud; 2024 May; 10(1):73. PubMed ID: 38720378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot Assessment of Platelet Thrombus Area and Contractile Force in Pediatric Congenital Heart Surgery Patients Using a Microfluidic Device.
    Wisniewski A; Norman A; Tsang S; Ricketts R; Sharma R; Suggs J; Vizzini S; Castro B; Raphael J; McNaull P; Gangemi J; Roeser M; Mazzeffi M
    J Cardiothorac Vasc Anesth; 2024 Sep; 38(9):2009-2016. PubMed ID: 38960807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard versus High Cardiopulmonary Bypass Flow Rate: A Randomized Controlled Subtrial Comparing Brain Injury Biomarker Release.
    Keiller AC; Axelsson M; Bragadottir G; Lannemyr L; Wijk J; Blennow K; Zetterberg H; Bagge RO
    J Cardiothorac Vasc Anesth; 2024 Jul; ():. PubMed ID: 39069384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Smoking on the Activated Clotting Time and the Incidence of Complications in Noncardiac Arterial Procedures.
    Roosendaal LC; van Os TEK; van Es N; Hoebink M; Wiersema AM; Blankensteijn JD; Jongkind V
    J Endovasc Ther; 2023 Oct; ():15266028231207027. PubMed ID: 37887702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributing factors to heparin resistance during cardiopulmonary bypass.
    Yamashiro T; Takami Y; Takagi Y
    J Artif Organs; 2024 Feb; ():. PubMed ID: 38367099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.